American Journal of Clinical Oncology-Cancer Clinical Trials

Article	Citations
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer	40
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody	40
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer	30
The Impact of COVID-19 on Patients With Cancer	28
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer	24
Breast and Cervical Cancer Screening Disparities in Transgender People	21
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment	20
Vaccination and Immune Checkpoint Inhibitors	19
Trends in Diagnosis and Treatment of Metastatic Cancer in the United States	19
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases	13
Social Determinants of Health in Oncology	13
Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma	13
Proton Pump Inhibitors and Cancer Risk	12
Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma	11
Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer	11
Cost-effectiveness Analysis of Ado-trastuzumab Emtansine (T-DM1) for the Adjuvant Treatment of Patients With Residual Invasive HER2+ Early Breast Cancer in the United States	10
Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy	10
Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma	10
Lower Levels of Trust in the Medical Profession Among White, Younger, and More-educated Individuals With Cancer	10
Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC)	9
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO)	9
Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors	9
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy	9
Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer	9
The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center	8

Management Strategies for Patients With Epithelioid Hemangioendothelioma	8
Interventions to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia	8
Clinical Trials Before, During, and After COVID-19 Pandemic	8
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors	8
Stereotactic Body Radiotherapy and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer	8
Differentiating Radiation Necrosis and Metastatic Progression in Brain Tumors Using Radiomics and Machine Learning	8
Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer	8
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer	7
Systematic Review of Treatments for Colorectal Metastases in Elderly Patients to Guide Surveillance Cessation Following Hepatic Resection for Colorectal Liver Metastases	7
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens	7
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies	7
Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer	7
Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections	7
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma	7
A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer	7
A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast	7
Tumor Necrotic Debris and High Nuclear Grade	7
Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer	7
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy	6
Regional Variation in Access to Oncologic Care and Racial Disparities Among Cervical Cancer Patients	6
Diagnostic Values of 8 Different Imaging Modalities for Preoperative Detection of Axillary Lymph Node Metastasis of Breast Cancer	6
Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in Oncology	6
Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases	6
Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma	6
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer	6
Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients	6
Prior Treatment for Non–small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy	6
Exercise Protocol With Limited Shoulder Range of Motion for 15 or 30 Days After Conservative Surgery for Breast Cancer With Oncoplastic Technique	6
Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers	5
Risk Factors for Recurrence and the Role of Radiotherapy in Low-grade Myofibroblastic Sarcoma	5
Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy	5
Rectosigmoid Cancer—Rectal Cancer or Sigmoid Cancer?	5
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer	5
Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy	5
Journey to Diversity in a University Radiation Oncology Residency Program	5
Prospective Study of PET/MRI Tumor Response During Chemoradiotherapy for Patients With Low-risk and Intermediate-risk p16-positive Oropharynx Cancer	5
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy	5
Sepsis Hospitalizations With Versus Without Cancer	5
Expansion of the LabBM Score	5
Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database	5
Benefits of a Multidisciplinary Women’s Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy	5
Temporal Trends and Predictors of Opioid Use Among Older Patients With Cancer	5
Concurrent Nab-paclitaxel and Radiotherapy	5
Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer	4
Physician Assessment of ChatGPT and Bing Answers to American Cancer Society’s Questions to Ask About Your Cancer	4
The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies	4
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer	4
Do Patients With Multiple Myeloma Enrolled in Clinical Trials Live Longer?	4
Prospective Longitudinal Assessment of Health-related Quality of Life in Patients With Brain Metastases Undergoing Radiation Therapy	4
Celecoxib and Myrtol	4

Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum	4
The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease	4
Intramedullary Nailing Versus Compound Plate Osteosynthesis in Pathologic Diaphyseal Humerus Fractures	4
Use of “Repurposed” Drugs in the Treatment of Epithelial Ovarian Cancer	4
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 2015	4
Clinical Uncertainty and Equipoise in the Management of Recurrent Glioblastoma	4
Intercostobrachial Nerve (ICBN) Preservation Versus Sacrifice in Axillary Dissection	4
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer	3
Extraskeletal Myxoid Chondrosarcoma	3
Preliminary Analysis of Cervical Cancer Immunotherapy	3
Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant	3
Stereotactic Body Radiotherapy for Prostate Cancer	3
Cardiac Angiosarcomas	3
Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy	3
Impact of Age on Overall Survival Among Children With Wilms Tumor	3
A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junc	3
Testosterone for Managing Treatment-related Fatigue in Patients With Metastatic Renal Cell Carcinoma	3
Characteristics and Growth Rate of Lung Metastases in Patients With Primary Gastrointestinal Malignancies and Lung-dominant Metastatic Disease	3
Diagnosis and Prognosis of Thyroid Cancer by Immune-related Genes	3
Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer	3
Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	3
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases	3
Cardiac Metastatic Tumors	3
The Efficacy and Safety of Pazopanib Plus Chemotherapy in Treating Recurrent or Persistent Ovarian Cancer	3
Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation	3
Reirradiation in Conservative Salvage of Recurrent Soft-tissue Sarcoma	3
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer	3
Pancreatic Cancer Clinical Treatment Trials Accrual	3
Cardiovascular Diseases Following Breast Cancer	3
Stereotactic Body Radiation Therapy (SBRT) for Spinal Metastases	3
Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors	3
Stereotactic Partial Breast Irradiation	3
Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei	3
Impact of Radiation on Cardiovascular Outcomes in Older Resectable Esophageal Cancer Patients With Medicare	3
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non−Small Cell Lung Cancer	3
Synovial Sarcoma of the Hand and Foot	3
Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors	3
Effect of Somatosensory Interaction Transcutaneous Electrical Acupoint Stimulation on Cancer-related Fatigue and Immunity	3
Sacituzumab Govitecan-hziy in Breast Cancer	3
Is There a Role for Perioperative Pelvic Radiotherapy in Surgically Resected Stage IV Rectal Cancer?	3
Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma	3
Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer	3
Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer	3
Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer	3
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation	3
The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy	2
Stereotactic Body Radiotherapy for Palliation of Hematuria Arising From Urothelial Carcinoma of the Kidney in Unfavorable Surgical Candidates	2
ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy	2
Impact of Extended Adjuvant Temozolamide Beyond 6 Months in the Management of Glioblastoma Patients	2
ACR–ARS Practice Parameter for the Performance of Total Body Irradiation	2
Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry	2
ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer	2
Evaluation of 5 Fraction Stereotactic Body Radiation Therapy (SBRT) for Osseous Renal Cell Carcinoma Metastases	2
Proton Beam Therapy for Locally Advanced Head and Neck Tumors	2
Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non–Small Cell Lung Cancer	2
High-dose Chemotherapy in Germ Cell Cancer Patients With Brain Metastases	2
Accelerated Partial Breast Irradiation	2
The Brown University Oncology Group Experience With FOLFOX + Nab-paclitaxel [FOLFOX-A] for Metastatic and Locally Advanced Pancreatic, BrUOG-292 and BrUOG-318	2
The Immunosuppression of Etoposide Deserves Attention in Chemoimmunotherapy	2
Long COVID in Cancer	2
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer	2
Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell Carcinoma	2
Phase II Study of the Modified Weekly Nab-paclitaxel Regimen in Previously Treated Patients With Advanced Non–Small Cell Lung Cancer	2
Accelerated Partial Breast Irradiation	2
Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations	2
A Pilot Study of Short-course Nivolumab and Low-dose Ipilimumab for Adjuvant Treatment of Melanoma	2
The Application of Nano-drug Delivery System With Sequential Drug Release Strategies in Cancer Therapy	2
A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials	2
The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients	2
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients	2
Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer	2
Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas Cancer	2
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer	2
Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer	2
Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status	2
Proceedings of the American Radium Society®’s 103rd Annual Meeting	2
Increased Resident Diversity Precedes Increased Faculty Diversity	2
Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non–Small Cell Lung Cancer	2
Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non–Small Cell Lung Cancer (NSCLC)	2
Preoperative Radiation Performed at a Nonsarcoma Center May Lead to Increased Wound Complications Following Resection in Patients With Soft Tissue Sarcomas	2

The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma	2
Hematologic Toxicity Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiation Therapy in Anal Cancer Patients	2
Advancements in NSCLC	2
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy	2
Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk N Stage	1
Cardiovascular Diseases Following Breast Cancer	1
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors	1
Proceedings of the American Radium Society® 104th Annual Meeting	1
Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer	1
Geographic Disparities in Access to Cancer Clinical Trials in Canada	1
Feasibility Trial of Intensity Modulated Proton Therapy to Reduce Toxicity in Anal Cancer Patients	1
The Influence of Hospital Characteristics on Patient Survival in Surgically Managed Metastatic Disease of Bone	1
Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases	1
A Novel Nomogram for Predicting Breast Cancer–specific Survival in Male Patients	1
The Prospective Observational Cohort and the Nested Randomized Controlled Trial in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC Study) Question the Reliance on Existing Evidence for the	1
MRI-guided Real-time Online Gated Stereotactic Body Radiation Therapy for Liver Tumors	1
Genomic and Molecular Characteristics of Ovarian Carcinosarcoma	1
Hospital Price Transparency Rule Exposes Muddied Costs for Head and Neck Radiotherapy in One State	1
Factors Associated With Lymph Node Yield and Effects of Lymph Node Density on Survival of Patients With Pulmonary Sarcomatoid Carcinoma	1
Clinical Characteristics and Outcomes of Eosinophilic Colitis in Patients With Cancer	1
Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?	1
A Scoring System to Select the Candidates for Adjuvant Chemotherapy Alone in High-Risk Early-Stage Cervical Cancer Patients With Pelvic Lymph Node Metastases After Surgery	1
Surveillance With Serial Imaging and CA 19-9 Tumor Marker Testing After Resection of Pancreatic Cancer	1
Prognostic Analysis of Lymphovascular Invasion in Stages I–III Colorectal Cancer	1
Factors Affecting Inpatient Mortality and Length of Stay in Nonmetastatic Colorectal Cancer	1
Prognostic Relevance of Negative Lymph Node Count in Resected Stage I–IIIa Small-cell Lung Cancer	1
Population-based Long-term Outcomes for Squamous Cell Carcinoma of the Nasal Cavity	1
Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer	1
A Preliminary Study of Immediate Intraperitoneal Chemotherapy for Stage III Colorectal Cancer	1
The Biology and Systemic Treatments Influence Survival in Advanced Gastrointestinal Cancers While the Controlled Trial of Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) Found That Surgical Re	1
Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy in the Treatment of Limited-Stage Small Cell Lung Cancer	1
Impact of Low-dose Chest CT Screening on the Association Between Rurality and Lung Cancer Outcomes	1
Management Strategies and Outcomes in Primary Liver Angiosarcoma	1
Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors	1
Patterns of Treatment Failure in Primary Central Nervous System Lymphoma	1
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies	1
Care Delivery in Cancer Patients With Asymptomatic COVID-19 Infection in a Tertiary, Safety-Net Hospital in Houston, Texas	1
A Simple, Novel Prognostic Score in Platinum Sensitive Relapsed Ovarian Cancer	1
Characteristics and Outcomes of Cancer Patients With Venous Thromboembolic Events After Treatment With Immune Checkpoint Inhibitors	1
Patterns of Use of Stereotactic Body Radiation Therapy Compared With Surgery for Definitive Treatment of Primary Early-stage Non–small Cell Lung Cancer	1
An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer	1
Surveillance Following Hepatic Resection for Colorectal Liver Metastases in Elderly Patients	1
Metaplastic Breast Carcinoma	1
The Cost of Simplicity for Early-stage Breast Cancer Treatment	1
Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy	1
Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients	1
Treatment of Cancer Pain	1
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors	1
Incidence and Predictors of Persistent Opioid Use in Survivors of Head and Neck Cancer Treated With Curative Radiation	1
A Real-World Study of the Incidence and Outcomes of Early-Onset Well-differentiated Neuroendocrine Neoplasms	1
Unknown Causes of Death in Cancer Patients	1
The Role of the Quality of Relationship in Couples Facing Treatment for Breast Cancer	1
Predictors of an Academic Career in Radiation Oncology 5 to 10 Years After Residency	1
Endometrial Cancer, BRCA1, and BRCA2 in the UK Biobank Cohort	1
Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation	1
Accelerated Partial Breast Irradiation	1
A Proposal to Modify the 8th IASLC System	1
Yttrium-90 Radioembolization of Colorectal Cancer Liver Metastases	1
Advancements in Diagnosis and Multimodal Treatment Strategies for Retroperitoneal Tumors	1
Does the Shift Away From Frame-based Stereotactic Radiosurgery Endanger Radiation Oncology’s Seat at the Table in Treating Functional Disorders?	1
Racial and Gender Differences in Patient Satisfaction Scores Among Oncologists	1
SBRT vs. Y90	1
In Reply: Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer	1
Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer	1
Patient Adherence in an Academic Medical Center’s Low-dose Computed Tomography Screening Program	1
Validation of Navigator-Assisted Hypofractionation (NAVAH) Program Survey to Aid American Indian Breast Cancer Patients	1
The Effect of Adjuvant Pelvic Radiotherapy on Distant Metastasis for Uterine Carcinosarcoma	1
ACR–ARS Practice Parameter on Informed Consent Radiation Oncology	1
Definitive Chemoradiotherapy Results in Synchronous Oligometastatic Non–small Cell Lung Cancer Patients	1
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non–Small Cell Lung Cancer	1
Proceedings of the American Radium Society® 105th Annual Meeting	1
Assessing Geographic Variation in Rates of Cervical Cancer and Recurrent or Metastatic Cervical Cancer Among Medicaid Enrollees	1
Radiation Treatment for Cancer of the Anal Margin	1
A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non–Small Cell Lung Cancer	1